Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (641-650 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|November 29, 2023
Current directions in the treatment of classical Hodgkin lymphomaFrank G Keller, Brad Kahl, Jonathan W Friedberg
Ejhaem|November 29, 2023
Clinical and haematological characteristics of 38 individuals with Hb G-Makassar in MalaysiaEzalia Esa, Ahmad Sabry Mohamad, Roszymah Hamzah, et al.
Ejhaem|November 29, 2023
Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patientsPierre Peterlin, Marie C Béné, Maxime Jullien, et al.
Ejhaem|November 29, 2023
Impact of COVID-19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell diseaseGabin Dubois, Emilie Virot, Manon Marie, et al.
Ejhaem|November 29, 2023
Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemiaCarmine Liberatore, Francesca Fioritoni, Annalisa Natale, et al.
Ejhaem|November 29, 2023
HLA haplotype frequencies and diversity in patients with hemoglobinopathiesGraziana M Scigliuolo, Wahid Boukouaci, Barbara Cappelli, et al.
Ejhaem|November 29, 2023
The pathobiology of select adolescent young adult lymphomasChristian Steidl, Robert Kridel, Michael Binkley, et al.
Ejhaem|November 29, 2023
Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutationGaël Vermeersch, Timothy Devos, Helena Devos, et al.
Ejhaem|November 29, 2023
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial resultsMarc S Raab, Elena Zamagni, Salomon Manier, et al.
Ejhaem|November 29, 2023
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trialPaul G Richardson, Thierry Facon, Christopher P Venner, et al.
Pageof 93

Showing results (641-650 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|November 29, 2023
Current directions in the treatment of classical Hodgkin lymphomaFrank G Keller, Brad Kahl, Jonathan W Friedberg
Ejhaem|November 29, 2023
Clinical and haematological characteristics of 38 individuals with Hb G-Makassar in MalaysiaEzalia Esa, Ahmad Sabry Mohamad, Roszymah Hamzah, et al.
Ejhaem|November 29, 2023
Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patientsPierre Peterlin, Marie C Béné, Maxime Jullien, et al.
Ejhaem|November 29, 2023
Impact of COVID-19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell diseaseGabin Dubois, Emilie Virot, Manon Marie, et al.
Ejhaem|November 29, 2023
Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemiaCarmine Liberatore, Francesca Fioritoni, Annalisa Natale, et al.
Ejhaem|November 29, 2023
HLA haplotype frequencies and diversity in patients with hemoglobinopathiesGraziana M Scigliuolo, Wahid Boukouaci, Barbara Cappelli, et al.
Ejhaem|November 29, 2023
The pathobiology of select adolescent young adult lymphomasChristian Steidl, Robert Kridel, Michael Binkley, et al.
Ejhaem|November 29, 2023
Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutationGaël Vermeersch, Timothy Devos, Helena Devos, et al.
Ejhaem|November 29, 2023
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial resultsMarc S Raab, Elena Zamagni, Salomon Manier, et al.
Ejhaem|November 29, 2023
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trialPaul G Richardson, Thierry Facon, Christopher P Venner, et al.
Pageof 93